Current Cancer Drug Targets

The Roles of Alternative Splicing in Tumor-immune Cell Interactions open Access plus

Volume: 20   Issue: 10
Pp: 729-740
Yue Wang, Honglei Zhang*, Baowei Jiao*, Jianyun Nie*, Xiyin Li, Wenhuan Wang and Hairui Wang
DOI:10.2174/1568009620666200619123725

Cancer Cell-derived Secretory Factors in Breast Cancer-associated Lung Metastasis: Their Mechanism and Future Prospects open Access plus

Volume: 20   Issue: 3
Pp: 168-186
Tabinda Urooj*, Bushra Wasim, Shamim Mushtaq, Syed Nudrat Nawaid Shah and Muzna Shah
DOI:10.2174/1568009620666191220151856

Combinatorial Inhibition of mTORC2 and Hsp90 Leads to a Distinctly Effective Therapeutic Strategy in Malignant Pheochromocytoma open Access plus

Volume: 19   Issue: 9
Pp: 698-706
Xiaohua Zhang, Fengbin Gao and Shan Zhong*
DOI:10.2174/1568009619666190206120615

Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer open Access plus

Volume: 19   Issue: 1
Pp: 74-80
Peng Liu, Hailin Tang, Jiali Wu, Xingsheng Qiu, Yanan Kong, Lijuan Zhang, Xinhua Xie* and Xiangsheng Xiao*
DOI:10.2174/1568009618666180709163718

Role of MicroRNAs in Treatment Response in Prostate Cancer open Access plus

Volume: 18   Issue: 10
Pp: 929-944
Anshuli Razdan, Paul de Souza* and Tara Laurine Roberts
DOI:10.2174/1568009618666180315160125

Noxa: Role in Cancer Pathogenesis and Treatment open Access plus

Volume: 18   Issue: 10
Pp: 914-928
Rami Z. Morsi, Rouba Hage-Sleiman, Hadile Kobeissy and Ghassan Dbaibo*
DOI:10.2174/1568009618666180308105048

HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles open Access plus

Volume: 17   Issue: 7
Pp: 637-649
Sarah L. Sammons, Donna L. Topping and Kimberly L. Blackwell*
DOI:10.2174/1568009617666170330120452

Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer open Access plus

Volume: 16   Issue: 4
Pp: 346-356
Xue-Qing Hu, Yang Sun, Eric Lau, Ming Zhao and Shi-Bing Su
DOI:10.2174/1568009616666151207105851

A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer open Access plus

Volume: 15   Issue: 8
Pp: 665-683
Otília Menyhart, Libero Santarpia and Balazs Gyorffy
DOI:10.2174/156800961508151001101742

Cancer Stem Cells in Solid and Liquid Tissues of Breast Cancer Patients: Characterization and Therapeutic Perspectives open Access plus

Volume: 15   Issue: 3
Pp: 256-269
Rena Chiotaki, Hara Polioudaki and Panayiotis A. Theodoropoulos
DOI:10.2174/1568009615666150211102503

Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo open Access plus

Volume: 14   Issue: 9
Pp: 860-871
Rui Zhou, Zongliang Lu, Kai Liu, Jing Guo, Jie Liu, Yong Zhou, Jian Yang, Mantian Mi and Hongxia Xu
DOI:10.2174/1568009614666141128104642

Pleiotropic Role of HSF1 in Neoplastic Transformation open Access plus

Volume: 14   Issue: 2
Pp: 144-155
Natalia Vydra, Agnieszka Toma and Wieslawa Widlak
DOI:10.2174/1568009614666140122155942

MicroRNAs as Critical Regulators Involved in Regulating Epithelial- Mesenchymal Transition open Access plus

Volume: 13   Issue: 9
Pp: 935-944
Xiaodi Zhao, Yuanyuan Lu, Yongzhan Nie and Daiming Fan
DOI:10.2174/15680096113136660099

Unveiling the Role of Nuclear Transport in Epithelial-to-Mesenchymal Transition open Access plus

Volume: 13   Issue: 9
Pp: 906-914
Asfar S. Azmi
DOI:10.2174/15680096113136660096

β-Catenin Knockdown in Liver Tumor Cells by a Cell Permeable Gamma Guanidine-based Peptide Nucleic Acid open Access plus

Volume: 13   Issue: 8
Pp: 867-878
Evan Delgado, Raman Bahal, Jing Yang, Jung M. Lee, Danith H Ly and Satdarshan P. S. Monga
DOI:10.2174/15680096113139990081

Signal Transduction in Human Cutaneous Melanoma and Target Drugs open Access plus

Volume: 13   Issue: 8
Pp: 843-866
Anatoly B. Uzdensky, Svetlana V. Demyanenko and Mikhail Y. Bibov
DOI:10.2174/1568009611313080004

Use of Single Nucleotide Polymorphism Array Technology to Improve the Identification of Chromosomal Lesions in Leukemia open Access plus

Volume: 13   Issue: 7
Pp: 791-810
Ilaria Iacobucci, Annalisa Lonetti, Cristina Papayannidis and Giovanni Martinelli
DOI:10.2174/15680096113139990089

Autophagy in Chronic Myeloid Leukaemia: Stem Cell Survival and Implication in Therapy open Access plus

Volume: 13   Issue: 7
Pp: 724-734
Gudmundur V. Helgason, Arunima Mukhopadhyay, Maria Karvela, Paolo Salomoni, Bruno Calabretta and Tessa L. Holyoake
DOI:10.2174/15680096113139990088

New Insights Into Biology of Chronic Myeloid Leukemia: Implications in Therapy open Access plus

Volume: 13   Issue: 7
Pp: 711-723
Michele Cea, Antonia Cagnetta, Alessio Nencioni, Marco Gobbi and Franco Patrone
DOI:10.2174/15680096113139990085

Unmet Needs in Ovarian Cancer: Dividing Histologic Subtypes to Exploit Novel Targets and Pathways open Access plus

Volume: 13   Issue: 6
Pp: 698-707
Vijaya Galic, Robert L. Coleman and Thomas J. Herzog
DOI:10.2174/15680096113139990002

Targeting Hypoxia for Sensitization of Tumors to Radio- and Chemotherapy open Access plus

Volume: 13   Issue: 6
Pp: 670-685
Khaled Ghattass, Rana Assah, Marwan El-Sabban and Hala Gali-Muhtasib
DOI:10.2174/15680096113139990004

Anti-inflammatory Phytochemicals for Chemoprevention of Colon Cancer open Access plus

Volume: 13   Issue: 5
Pp: 542-557
Venkateshwar Madka and Chinthalapally V. Rao
DOI:10.2174/15680096113139990036

miRNAs in Cancer Prevention and Treatment and as Molecular Targets for Natural Product Anticancer Agents open Access plus

Volume: 13   Issue: 5
Pp: 519-541
Biyun Qian, Subhasree A. Nag, Yuliang Su, Sukesh Voruganti, Jiang-Jiang Qin, Ruiwen Zhang and William C. S. Cho
DOI:10.2174/15680096113139990031

VEGF in Tumor Progression and Targeted Therapy open Access plus

Volume: 13   Issue: 4
Pp: 423-443
Vladimir P. Chekhonin, Sergey A. Shein, Anna A. Korchagina and Olga I. Gurina
DOI:10.2174/15680096113139990074

Nanomedicines as Cancer Therapeutics: Current Status open Access plus

Volume: 13   Issue: 4
Pp: 362-378
Sohail Akhter, Iqbal Ahmad, Mohammad Zaki Ahmad, Farshad Ramazani, Anjali Singh, Ziyaur Rahman, Farhan Jalees Ahmad, Gert Storm and Robbert J. Kok
DOI:10.2174/1568009611313040002

P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives open Access plus

Volume: 13   Issue: 3
Pp: 326-346
Ziyad Binkhathlan and Afsaneh Lavasanifar
DOI:10.2174/15680096113139990076

Targeting Tyrosine Kinase Receptors in Hepatocellular Carcinoma open Access plus

Volume: 13   Issue: 3
Pp: 300-312
Jordi Muntane, Angel J. De la Rosa, Fernando Docobo, Rocio Garcia-Carbonero and Francisco J. Padillo
DOI:10.2174/15680096113139990075

Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling open Access plus

Volume: 13   Issue: 2
Pp: 188-204
Thomas W. Grunt and Gabriella L. Mariani
DOI:10.2174/1568009611313020008

Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer open Access plus

Volume: 13   Issue: 2
Pp: 175-187
Xiaobei Zhang, Xi-ru Li and Jin Zhang
DOI:10.2174/1568009611313020007

Cancer Stem Cell as a Potential Therapeutic Target in Hepatocellular Carcinoma open Access plus

Volume: 12   Issue: 9
Pp: 1081-1094
Roberta W.C. Pang and Ronnie T.P. Poon
DOI:10.2174/15680096112091081

Targeted Therapy for Liver Cancer: Updated Review in 2012 open Access plus

Volume: 12   Issue: 9
Pp: 1062-1072
Masatoshi Kudo
DOI:10.2174/15680096112091062

Scope of Nanotechnology-based Radiation Therapy and Thermotherapy Methods in Cancer Treatment open Access plus

Volume: 12   Issue: 8
Pp: 998-1015
Mohamadreza K. Bakht, Mahdi Sadeghi, Milad Pourbaghi-Masouleh and Claudio Tenreiro
DOI:10.2174/156800912803251216

Membrane Transporters as Determinants of the Pharmacology of Platinum Anticancer Drugs open Access plus

Volume: 12   Issue: 8
Pp: 962-986
Johnson J. Liu, Jun Lu and Mark J. McKeage
DOI:10.2174/156800912803251199

A Comprehensive Overview of Targeted Therapy in Metastatic Renal Cell Carcinoma open Access plus

Volume: 12   Issue: 7
Pp: 857-872
Z. Mihaly, Z. Sztupinszki, P. Surowiak and B. Gyorffy
DOI:10.2174/156800912802429265

Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma open Access plus

Volume: 12   Issue: 7
Pp: 838-846
P. Tagliaferri, M. Rossi, M. T. Di Martino, N. Amodio, E. Leone, A. Gulla, A. Neri and P. Tassone
DOI:10.2174/156800912802429355

MicroRNAs in the Pathobiology of Multiple Myeloma open Access plus

Volume: 12   Issue: 7
Pp: 823-837
Marta Lionetti, Luca Agnelli, Luigia Lombardi, Pierfrancesco Tassone and Antonino Neri
DOI:10.2174/156800912802429274

Mouse Models as a Translational Platform for the Development of New Therapeutic Agents in Multiple Myeloma open Access plus

Volume: 12   Issue: 7
Pp: 814-822
P. Tassone, P. Neri, R. Burger, M. T. Di Martino, E. Leone, N. Amodio, M. Caraglia and P. Tagliaferri
DOI:10.2174/156800912802429292

Molecular Targets for the Treatment of Multiple Myeloma open Access plus

Volume: 12   Issue: 7
Pp: 757-767
Marco Rossi, Maria Teresa Di Martino, Eugenio Morelli, Marzia Leotta, Antonietta Rizzo, Anna Grimaldi, Gabriella Misso, Pierfrancesco Tassone and Michele Caraglia
DOI:10.2174/156800912802429300

Emerging Roles for Modulation of microRNA Signatures in Cancer Chemoprevention open Access plus

Volume: 12   Issue: 6
Pp: 716-740
K. Neelakandan, P. Babu and S. Nair
DOI:10.2174/156800912801784875

High CXCR4 Expression Correlates with Sunitinib Poor Response in Metastatic Renal Cancer open Access plus

Volume: 12   Issue: 6
Pp: 693-702
C. D'Alterio, L. Portella, A. Ottaiano, M. Rizzo, G. Carteni, S. Pignata, G. Facchini, S. Perdona, G. Di Lorenzo, R. Autorino, R. Franco, A. La Mura, O. Nappi, G. Castello and S. Scala
DOI:10.2174/156800912801784820

Two Novel GPER Agonists Induce Gene Expression Changes and Growth Effects in Cancer Cells open Access plus

Volume: 12   Issue: 5
Pp: 531-542
R. Lappano, C. Rosano, M. F. Santolla, M. Pupo, E. M. De Francesco, P. De Marco, M. Ponassi, A. Spallarossa, A. Ranise and M. Maggiolini
DOI:10.2174/156800912800673284

Emerging Therapies in Chronic Myeloid Leukemia open Access plus

Volume: 12   Issue: 5
Pp: 458-470
J. Gora-Tybor
DOI:10.2174/156800912800673202

An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors open Access plus

Volume: 12   Issue: 4
Pp: 439-452
Nicola Tinari, Michele De Tursi, Antonino Grassadonia, Marinella Zilli, Liborio Stuppia, Stefano Iacobelli and Clara Natoli
DOI:10.2174/156800912800190884

Genetic Variants in Genes Involved in Mechanisms of Chemoresistance to Anticancer Drugs open Access plus

Volume: 12   Issue: 4
Pp: 402-438
J. J.G. Marin, O. Briz, M. J. Monte, A. G. Blazquez and R. I.R. Macias
DOI:10.2174/156800912800190875

Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance open Access plus

Volume: 12   Issue: 3
Pp: 197-209
T. E. Taylor, F. B. Furnari and W. K. Cavenee
DOI:10.2174/156800912799277557

Nanotech Revolution for the Anti-Cancer Drug Delivery through Blood- Brain-Barrier open Access plus

Volume: 12   Issue: 3
Pp: 186-196
M. Caraglia, G. De Rosa, G. Salzano, D. Santini, M. Lamberti, P. Sperlongano, A. Lombardi, A. Abbruzzese and R. Addeo
DOI:10.2174/156800912799277421

Anticancer Drugs Aimed at E6 and E7 Activity in HPV-Positive Cervical Cancer open Access plus

Volume: 12   Issue: 2
Pp: 170-184
S. Tan, E. G.E. de Vries, A. G.J. van der Zee and S. de Jong
DOI:10.2174/156800912799095135

Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung Cancer open Access plus

Volume: 12   Issue: 2
Pp: 107-123
S. A. Kono, L. E. Heasley, R. C. Doebele and D. R. Camidge
DOI:10.2174/156800912799095144

Targeting ATP7A to Increase the Sensitivity of Neuroblastoma Cells to Retinoid Therapy open Access plus

Volume: 11   Issue: 7
Pp: 826-836
B. B. Cheung and G. M. Marshall
DOI:10.2174/156800911796798968

Strategies for Overcoming Inherent and Acquired Resistance to EGFR Inhibitors by Targeting Downstream Effectors in the RAS/PI3K Pathway open Access plus

Volume: 10   Issue: 8
Pp: 824-833
A. J. Weickhardt, N. C. Tebbutt and J. M. Mariadason
DOI:10.2174/156800910793357961

Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function open Access plus

Volume: 10   Issue: 2
Pp: 155-167
A. K. Gandhi, J. Kang, L. Capone, A. Parton, L. Wu, L. H. Zhang, D. Mendy, A. Lopez-Girona, T. Tran, L. Sapinoso, W. Fang, S. Xu, G. Hampton, J. B. Bartlett and P. Schafer
DOI:10.2174/156800910791054239

Potential Uses of MicroRNA in Lung Cancer Diagnosis, Prognosis, and Therapy open Access plus

Volume: 9   Issue: 4
Pp: 572-594
Qi Zhao Wang, William Xu, Nagy Habib and Ruian Xu
DOI:10.2174/156800909788486731

S100A8 and S100A9 Overexpression Is Associated with Poor Pathological Parameters in Invasive Ductal Carcinoma of the Breast open Access plus

Volume: 8   Issue: 4
Pp: 243-252
Kazumori Arai, Sachiko Takano, Takumi Teratani, Yasuhiro Ito, Toshihiro Yamada and Ryushi Nozawa
DOI:10.2174/156800908784533445

Nutritional Modulation of Terminal End Buds: Its Relevance to Breast Cancer Prevention open Access plus

Volume: 7   Issue: 5
Pp: 465-474
Leena Hilakivi-Clarke
DOI:10.2174/156800907781386641

Ribonucleotide Reductase Inhibitors and Future Drug Design open Access plus

Volume: 6   Issue: 5
Pp: 409-431
J. Shao, B. Zhou, Bernard Chu and Y. Yen
DOI:10.2174/156800906777723949

Liposomal Muramyl Tripeptide Phosphatidylethanolamine: Targeting and Activating Macrophages for Adjuvant Treatment of Osteosarcoma open Access plus

Volume: 6   Issue: 2
Pp: 123-133
A. Nardin, M. L. Lefebvre, K. Labroquere, O. Faure and J. P. Abastado
DOI:10.2174/156800906776056473